ArticleWorld journal of surgical oncology2025
Chondroitin sulfate proteoglycan 4 (CSPG4) overexpression as an oncogenic driver and prognostic marker for unfavorable outcomes in hepatocellular carcinoma.
Changjie Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.